June 13 (Reuters) – Johnson & Johnson: * NEW TALVEY® (TALQUETAMAB-TGVS) PLUS DARZALEX FASPRO® (DARATUMUMAB AND HYALURONIDASE-FIHJ) DATA DEMONSTRATE THE STRENGTH OF A BISPECIFIC COMBINATION IN
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
PM Modi, President Macron to chart future of India-France tech cooperation at Bharat Innovates 2026
Nice [France], June 14 (ANI): Technology and innovation are poised to take centre stage as…
New York [US], June 14 (ANI): Morocco head coach Mohamed Ouahbi expressed confidence in the…
"Amazing experience", says Brazilian fan despite 1-1 draw against Morocco
VIDEO SHOWS: FANS LEAVING NEW JERSEY STADIUM AFTER 1-1 DRAW BETWEEN MOROCCO AND BRAZIL /…
